Jian-Xia LU, Shao-lan ZHANG, Zheng-Ping CHEN, Wan-Xiang WANG, Zhong-Qian LU, Juan ZHİ

Polymorphism in Integrin ITGA2 is Associated with Ischemic Stroke and Altered Serum Cholesterol in Chinese Individuals

Background:Recent studies havereported contrasting results regard-ingtheassociation ofpolymorphisms intwointegrin genes, ITGA2and ITGB3, with ischemic stroke.Aims:Thepresent study aimed to investigate thecorrelation betweentheITGA2 C807T andITGB3 T176C polymorphic lociwithischemicstroke, as well as plasma lipid and lipoprotein levels.Study Design: Case control study.Methods:Human venous blood samples werecollected frompatientsadmitted forischemic stroke (n=350, 'patients') andhealthy individu-als(n=300, 'controls'). Blood wasgenotyped at these locibypoly-merase chain reaction-restriction fragment length polymorphism. Plas-malipidandlipoprotein levels weremeasured byroutine enzymatic,masking, and turbidimetry methods.Results:Asexpected, totalcholesterol, triglycerides, andlow-densitylipoprotein were allsignificantly higher inpatients thanincontrols(p

PDF

___

Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic stroke. Nat Rev Neurol 2011;7:369-78. [CrossRef]
Huo Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand 2001;173:35-43. [CrossRef]
Elkind MS. Inflammation, atherosclerosis, and stroke. Neurologist 2006;12:140-8. [CrossRef]
Rivera J, Lozano ML, Navarro-Nş-ez L, Vicente V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009;94:700-11. [CrossRef]
Nikolopoulos GK, Tsantes AE, Bagos PG, Travlou A, Vaiopoulos G. In- tegrin, alpha 2 gene C807T polymorphism and risk of ischemic stroke:a meta-analysis. Thromb Res 2007;119:501-10. [CrossRef]
Wei YS, Lan Y, Liu YG, Meng LQ, Xu QQ, Xie HY. Association of the integrin gene polymorphisms with ischemic stroke and plasma lipid levels. Zhonghua Yi Xue Yi Chuang Xue Za Zhi 2009;26:211-5.
Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000;31:1628-33. [CrossRef]
Maakaroun A, Regina S, Delahousse B, Saudeau D, Gruel Y. Ischemic strokes and homozygosity for the alpha2 807T allele of the platelet collagen receptor in young monozygotic twins. Blood Coagul Fibrinolysis 2003;14:83-5. [CrossRef]
Matarin M, Brown WM, Hardy JA, Rich SS, Singleton AB, Brown RD Jr, et al. Association of integrin alpha gene variants with ischemic stroke. J Cereb Blood Flow Metab 2008;28:81-9. [CrossRef]
Xavier UR, Joaquín SL. Stoke, diagnosis and therapeutic management of cerebrovascular disease. Rev Esp Cardiol 2007;60:753-69.
Orii KE, Aoyama T, Wakui K, Fukushima Y, Miyajima H, Yamaguchi S, et al. Genomic and Mutational Analysis of the Mitochondrial Trifunctional Protein ?-Subunit (HADHB) Gene in Patients with Trifunctional Protein Deficiency. Hum Mol Genet 1997;6:1215-24. [CrossRef]
Hellewell PG. Adhesion molecule strategies. Pulm Pharmacol Ther 1999;12:137-41. [CrossRef]
Jacquelin B, Rozenshteyn D, Kanaji S, Koziol JA, Nurden AT, Kunicki TJ. Characterization of Inherited Differences in Transcription of the Human In- tegrin alpha 2 Gene. J Biol Chem 2001;276:23518-24. [CrossRef]
Vijayan KV, Liu Y, Dong JF, Bray PF. Enhanced activation of mitogen-ac- tivated protein kinase and myosin light chain kinase by the Pro33 polymor- phism of integrin beta 3. J Biol Chem 2003;278:3860-7. [CrossRef]
Payne KE, Bray PF, Grant PJ, Carter AM. Beta3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity. Atherosclerosis 2008;198:280-6. [CrossRef]
Manginas A, Tsiavou A, Chaidaroglou A, Giamouzis G, Degiannis D, Pan- agiotakos D, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008;19:575-82. [CrossRef]
Giusti B, Gori AM, Marcucci R, Sestini I, Saracini C, Paniccia R, et al. Role of glycoprotein Ia gene polymorphisms in determining plate- let function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment. Atherosclerosis 2008;196:341-8. [CrossRef]